Content Desk1 min readFDA Announces Revision in Presenting Risk & Efficacy Information in DTC Prescription Drug PromotionFDA announced the availability of Final Guideline for Industry on presenting quantitative efficacy and risk information in...
Content Desk2 min readFDA Publishes Final Rule on Requirement for Patient MedicationFDA is proposing to amend its drug product labeling rules for Medication Guide and other information templates provided to...
Content Desk1 min readUpdate on In-Person, Face-to-Face ANDA MeetingMarch 29, 2023 Recent update by #FDA: #Face-to-Face Meetings are back for ANDAs: The FDA's generic drug program will restart holding...